Pancreatic carcinoma
RecruitingEvaluation of Hydrocortisone, Octreotide, and Teres Ligament Patch Combination to Prevent Complications After Pancreatoduodenectomy in Patients with Pancreatic Head Cancer or IPMN
Evaluation of Hydrocortisone, Octreotide, and Teres Ligament Patch Combination to Prevent Complications After Pancreatoduodenectomy in Patients with Pancreatic Head Cancer or IPMN
- Disease:Pancreatic carcinoma
- Substances:HydrocortisoneOctreotide Acetate
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Hydrocortisone
